EBIT at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s EBIT?
- Artiva Biotherapeutics, Inc. (ARTV) reported EBIT of -$24.43M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s EBIT changed year-over-year?
- Artiva Biotherapeutics, Inc.'s EBIT decreased by 10.2% year-over-year, from -$22.17M to -$24.43M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s EBIT?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s EBIT has grown at a 71.1% compound annual growth rate (CAGR), from -$30.67M to -$89.81M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.